AKBA · ISSUER CIK 1517022
Akebia Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Akebia Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 10, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 202616:08 | Aug 6, 2026 | AKBA | CEO and President, Director | M · Exercise | $0.63 | +350,000 | 3,718,564 | +10% | $221K |